Created
October 4, 2023 13:50
-
-
Save sbamin/8af41269c99d359986999014bd9ad814 to your computer and use it in GitHub Desktop.
Provide citation in BibTeX format: See endnote https://endnote.com/style_download/bibtex-export/ or https://app.bibguru.com/
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
@ARTICLE{Bakas2020-ee, | |
title = "{iGLASS}: imaging integration into the Glioma Longitudinal | |
Analysis Consortium", | |
author = "Bakas, Spyridon and Ormond, David Ryan and Alfaro-Munoz, Kristin | |
D and Smits, Marion and Cooper, Lee Alex Donald and Verhaak, Roel | |
and Poisson, Laila M", | |
journal = "Neuro. Oncol.", | |
volume = 22, | |
number = 10, | |
pages = "1545-1546", | |
month = oct, | |
year = 2020, | |
url = "http://dx.doi.org/10.1093/neuonc/noaa160", | |
language = "en", | |
issn = "1522-8517, 1523-5866", | |
pmid = "32644158", | |
doi = "10.1093/neuonc/noaa160", | |
pmc = "PMC7566469" | |
} | |
@ARTICLE{Varn2022-bt, | |
title = "Glioma progression is shaped by genetic evolution and | |
microenvironment interactions", | |
author = "Varn, Frederick S and Johnson, Kevin C and Martinek, Jan and | |
Huse, Jason T and Nasrallah, Maclean P and Wesseling, Pieter and | |
Cooper, Lee A D and Malta, Tathiane M and Wade, Taylor E and | |
Sabedot, Thais S and Brat, Daniel and Gould, Peter V and | |
W{\"o}ehrer, Adelheid and Aldape, Kenneth and Ismail, Azzam and | |
Sivajothi, Santhosh K and Barthel, Floris P and Kim, Hoon and | |
Kocakavuk, Emre and Ahmed, Nazia and White, Kieron and Datta, | |
Indrani and Moon, Hyo-Eun and Pollock, Steven and Goldfarb, | |
Christine and Lee, Ga-Hyun and Garofano, Luciano and Anderson, | |
Kevin J and Nehar-Belaid, Djamel and Barnholtz-Sloan, Jill S and | |
Bakas, Spyridon and Byrne, Annette T and D'Angelo, Fulvio and | |
Gan, Hui K and Khasraw, Mustafa and Migliozzi, Simona and Ryan | |
Ormond, D and Paek, Sun Ha and Van Meir, Erwin G and Walenkamp, | |
Annemiek M E and Watts, Colin and Weiss, Tobias and Weller, | |
Michael and Palucka, Karolina and Stead, Lucy F and Poisson, | |
Laila M and Noushmehr, Houtan and Iavarone, Antonio and Verhaak, | |
Roel G W and Alfaro, Kristin D and Amin, Samirkumar B and | |
Ashley, David M and Bock, Christoph and Brodbelt, Andrew and | |
Bulsara, Ketan R and Castro, Ana Valeria and Connelly, Jennifer | |
M and Costello, Joseph F and de Groot, John F and Finocchiaro, | |
Gaetano and French, Pim J and Golebiewska, Anna and Hau, Ann C | |
and Hong, Chibo and Horbinski, Craig and Kannan, Kasthuri S and | |
Kouwenhoven, Mathilde C M and Lasorella, Anna and LaViolette, | |
Peter S and Ligon, Keith L and Lowman, Allison K and Mehta, | |
Shwetal and Miletic, Hrvoje and Molinaro, Annette M and Ng, Ho | |
Keung and Niclou, Simone P and Niers, Johanna M and Phillips, | |
Joanna J and Rabadan, Raul and Rao, Ganesh and Reifenberger, | |
Guido and Sanai, Nader and Short, Susan C and Smitt, Peter | |
Sillevis and Sloan, Andrew E and Smits, Marion and Snyder, James | |
M and Suzuki, Hiromichi and Tabatabai, Ghazaleh and Tanner, | |
Georgette and Tomaszewski, William H and Wells, Michael and | |
Westerman, Bart A and Wheeler, Helen and Xie, Jichun and Alfred | |
Yung, W K and Zadeh, Gelareh and Zhao, Junfei and Verhaak, Roel | |
G W", | |
abstract = "SummaryThe factors driving therapy resistance in diffuse glioma | |
remain poorly understood. To identify treatment-associated | |
cellular and genetic changes, we analyzed RNA and/or DNA | |
sequencing data from the temporally separated tumor pairs of 304 | |
adult patients with isocitrate dehydrogenase (IDH)-wild-type and | |
IDH-mutant glioma. Tumors recurred in distinct manners that were | |
dependent on IDH mutation status and attributable to changes in | |
histological feature composition, somatic alterations, and | |
microenvironment interactions. Hypermutation and acquired CDKN2A | |
deletions were associated with an increase in proliferating | |
neoplastic cells at recurrence in both glioma subtypes, | |
reflecting active tumor growth. IDH-wild-type tumors were more | |
invasive at recurrence, and their neoplastic cells exhibited | |
increased expression of neuronal signaling programs that | |
reflected a possible role for neuronal interactions in promoting | |
glioma progression. Mesenchymal transition was associated with | |
the presence of a myeloid cell state defined by specific | |
ligand-receptor interactions with neoplastic cells. | |
Collectively, these recurrence-associated phenotypes represent | |
potential targets to alter disease progression.", | |
journal = "Cell", | |
publisher = "Elsevier", | |
volume = 0, | |
number = 0, | |
month = may, | |
year = 2022, | |
url = "http://www.cell.com/article/S0092867422005360/abstract", | |
language = "en", | |
issn = "0092-8674, 1097-4172", | |
doi = "10.1016/j.cell.2022.04.038" | |
} | |
@ARTICLE{Barthel2019-kv, | |
title = "Longitudinal molecular trajectories of diffuse glioma in adults", | |
author = "Barthel, Floris P and Johnson, Kevin C and Varn, Frederick S and | |
Moskalik, Anzhela D and Tanner, Georgette and Kocakavuk, Emre and | |
Anderson, Kevin J and Abiola, Olajide and Aldape, Kenneth and | |
Alfaro, Kristin D and Alpar, Donat and Amin, Samirkumar B and | |
Ashley, David M and Bandopadhayay, Pratiti and Barnholtz-Sloan, | |
Jill S and Beroukhim, Rameen and Bock, Christoph and Brastianos, | |
Priscilla K and Brat, Daniel J and Brodbelt, Andrew R and Bruns, | |
Alexander F and Bulsara, Ketan R and Chakrabarty, Aruna and | |
Chakravarti, Arnab and Chuang, Jeffrey H and Claus, Elizabeth B | |
and Cochran, Elizabeth J and Connelly, Jennifer and Costello, | |
Joseph F and Finocchiaro, Gaetano and Fletcher, Michael N and | |
French, Pim J and Gan, Hui K and Gilbert, Mark R and Gould, Peter | |
V and Grimmer, Matthew R and Iavarone, Antonio and Ismail, Azzam | |
and Jenkinson, Michael D and Khasraw, Mustafa and Kim, Hoon and | |
Kouwenhoven, Mathilde C M and LaViolette, Peter S and Li, Meihong | |
and Lichter, Peter and Ligon, Keith L and Lowman, Allison K and | |
Malta, Tathiane M and Mazor, Tali and McDonald, Kerrie L and | |
Molinaro, Annette M and Nam, Do-Hyun and Nayyar, Naema and Ng, Ho | |
Keung and Ngan, Chew Yee and Niclou, Simone P and Niers, Johanna | |
M and Noushmehr, Houtan and Noorbakhsh, Javad and Ormond, D Ryan | |
and Park, Chul-Kee and Poisson, Laila M and Rabadan, Raul and | |
Radlwimmer, Bernhard and Rao, Ganesh and Reifenberger, Guido and | |
Sa, Jason K and Schuster, Michael and Shaw, Brian L and Short, | |
Susan C and Smitt, Peter A Sillevis and Sloan, Andrew E and | |
Smits, Marion and Suzuki, Hiromichi and Tabatabai, Ghazaleh and | |
Van Meir, Erwin G and Watts, Colin and Weller, Michael and | |
Wesseling, Pieter and Westerman, Bart A and Widhalm, Georg and | |
Woehrer, Adelheid and Yung, W K Alfred and Zadeh, Gelareh and | |
Huse, Jason T and De Groot, John F and Stead, Lucy F and Verhaak, | |
Roel G W and Barthel, Floris P and Johnson, Kevin C and Varn, | |
Frederick S and Moskalik, Anzhela D and Tanner, Georgette and | |
Kocakavuk, Emre and Anderson, Kevin J and Aldape, Kenneth and | |
Alfaro, Kristin D and Amin, Samirkumar B and Ashley, David M and | |
Bandopadhayay, Pratiti and Barnholtz-Sloan, Jill S and Beroukhim, | |
Rameen and Bock, Christoph and Brastianos, Priscilla K and Brat, | |
Daniel J and Brodbelt, Andrew R and Bulsara, Ketan R and | |
Chakrabarty, Aruna and Chuang, Jeffrey H and Claus, Elizabeth B | |
and Cochran, Elizabeth J and Connelly, Jennifer and Costello, | |
Joseph F and Finocchiaro, Gaetano and Fletcher, Michael N and | |
French, Pim J and Gan, Hui K and Gilbert, Mark R and Gould, Peter | |
V and Iavarone, Antonio and Ismail, Azzam and Jenkinson, Michael | |
D and Khasraw, Mustafa and Kim, Hoon and Kouwenhoven, Mathilde C | |
M and LaViolette, Peter S and Lichter, Peter and Ligon, Keith L | |
and Lowman, Allison K and Malta, Tathiane M and McDonald, Kerrie | |
L and Molinaro, Annette M and Nam, Do-Hyun and Ng, Ho Keung and | |
Niclou, Simone P and Niers, Johanna M and Noushmehr, Houtan and | |
Ormond, D Ryan and Park, Chul-Kee and Poisson, Laila M and | |
Rabadan, Raul and Radlwimmer, Bernhard and Rao, Ganesh and | |
Reifenberger, Guido and Sa, Jason K and Short, Susan C and Smitt, | |
Peter A Sillevis and Sloan, Andrew E and Smits, Marion and | |
Suzuki, Hiromichi and Tabatabai, Ghazaleh and Van Meir, Erwin G | |
and Watts, Colin and Weller, Michael and Wesseling, Pieter and | |
Westerman, Bart A and Woehrer, Adelheid and Yung, W K Alfred and | |
Zadeh, Gelareh and Huse, Jason T and De Groot, John F and Stead, | |
Lucy F and Verhaak, Roel G W and {The GLASS Consortium}", | |
abstract = "The evolutionary processes that drive universal therapeutic | |
resistance in adult patients with diffuse glioma remain | |
unclear1,2. Here we analysed temporally separated DNA-sequencing | |
data and matched clinical annotation from 222 adult patients with | |
glioma. By analysing mutations and copy numbers across the three | |
major subtypes of diffuse glioma, we found that driver genes | |
detected at the initial stage of disease were retained at | |
recurrence, whereas there was little evidence of | |
recurrence-specific gene alterations. Treatment with alkylating | |
agents resulted in a hypermutator phenotype at different rates | |
across the glioma subtypes, and hypermutation was not associated | |
with differences in overall survival. Acquired aneuploidy was | |
frequently detected in recurrent gliomas and was characterized by | |
IDH mutation but without co-deletion of chromosome arms 1p/19q, | |
and further converged with acquired alterations in the cell cycle | |
and poor outcomes. The clonal architecture of each tumour | |
remained similar over time, but the presence of subclonal | |
selection was associated with decreased survival. Finally, there | |
were no differences in the levels of immunoediting between | |
initial and recurrent gliomas. Collectively, our results suggest | |
that the strongest selective pressures occur during early glioma | |
development and that current therapies shape this evolution in a | |
largely stochastic manner.", | |
journal = "Nature", | |
month = nov, | |
year = 2019, | |
url = "https://doi.org/10.1038/s41586-019-1775-1", | |
issn = "0028-0836, 1476-4687", | |
doi = "10.1038/s41586-019-1775-1" | |
} | |
@ARTICLE{Aldape2018-qf, | |
title = "Glioma Through the Looking {GLASS}: Molecular Evolution of | |
Diffuse Gliomas and the Glioma Longitudinal {AnalySiS} Consortium", | |
author = "Aldape, Kenneth and Amin, Samirkumar B and Ashley, David M and | |
Barnholtz-Sloan, Jill S and Bates, Amanda J and Beroukhim, Rameen | |
and Bock, Christoph and Brat, Daniel J and Claus, Elizabeth B and | |
Costello, Joseph F and de Groot, John F and Finocchiaro, Gaetano | |
and French, Pim J and Gan, Hui K and Griffith, Brent and | |
Herold-Mende, Christel C and Horbinski, Craig and Iavarone, | |
Antonio and Kalkanis, Steven N and Karabatsou, Konstantina and | |
Kim, Hoon and Kouwenhoven, Mathilde C M and McDonald, Kerrie L | |
and Miletic, Hrvoje and Nam, Do-Hyun and Ng, Ho Keung and Niclou, | |
Simone P and Noushmehr, Houtan and Ormond, Ryan and Poisson, | |
Laila M and Reifenberger, Guido and Roncaroli, Federico and Sa, | |
Jason K and Sillevis Smitt, Peter A E and Smits, Marion and | |
Souza, Camila F and Tabatabai, Ghazaleh and Van Meir, Erwin G and | |
Verhaak, Roel G W and Watts, Colin and Wesseling, Pieter and | |
Woehrer, Adelheid and Yung, W K Alfred and Jungk, Christine and | |
Hau, Ann-Christin and van Dyck, Eric and Westerman, Bart A and | |
Yin, Julia and Abiola, Olajide and Zeps, Nikolaj and Grimmond, | |
Sean and Buckland, Michael and Khasraw, Mustafa and Sulman, Erik | |
P and Muscat, Andrea M and Stead, Lucy and {GLASS Consortium}", | |
abstract = "Adult diffuse gliomas are a diverse group of brain neoplasms that | |
inflict a high emotional toll on patients and their families. The | |
Cancer Genome Atlas (TCGA) and similar projects have provided a | |
comprehensive understanding of the somatic alterations and | |
molecular subtypes of glioma at diagnosis. However, gliomas | |
undergo significant cellular and molecular evolution during | |
disease progression. We review the current knowledge on the | |
genomic and epigenetic abnormalities in primary tumors and after | |
disease recurrence, highlight the gaps in the literature, and | |
elaborate on the need for a new multi-institutional effort to | |
bridge these knowledge gaps and how the Glioma Longitudinal | |
AnalySiS Consortium (GLASS) aims to systemically catalog the | |
longitudinal changes in gliomas. The GLASS initiative will | |
provide essential insights into the evolution of glioma toward a | |
lethal phenotype, with the potential to reveal targetable | |
vulnerabilities, and ultimately, improved outcomes for a patient | |
population in need.", | |
journal = "Neuro. Oncol.", | |
month = feb, | |
year = 2018, | |
url = "https://academic.oup.com/neuro-oncology/advance-article-abstract/doi/10.1093/neuonc/noy020/4843984", | |
language = "en", | |
issn = "1522-8517, 1523-5866", | |
pmid = "29432615", | |
doi = "10.1093/neuonc/noy020" | |
} |
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment